Neurodevelopmental Outcomes and Fluconazole Prophylaxis

Completed · Has a placebo group

Conditions studied: Neurodevelopmental Outcomes

In brief

The purpose of this study is to compare the neurodevelopmental outcome and quality of life between the fluconazole-treated and the placebo-treated patients that were enrolled in a fluconazole prophylaxis study that occurred in the investigators' neonatal intensive care unit (NICU) between 1998-2000.

Key facts

Study ID

NCT00975949

Run by

University of Virginia

People needed

39

Starts

2008-06-01

Expected to finish

2010-06-01

Last updated by the study team

2013-01-15

Who can join

Age: 7 and older, up to 10. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Parents or guardians and their infants who survived and were enrolled in our initial study of fluconazole prophylaxis for prevention of fungal colonization and infection in preterm infants < 1000 grams

You may not qualify if…

• Persons not meeting the inclusion criteria

Where it is running

• University of Virginia Neonatal Intensive Care Unit — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.